Search all trials

Find therapies in clinical trials near you – page 854

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 101

3 961 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Axicabtagene Ciloleucel

Contact Research Centre

Bladder transitional cell carcinoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Metastatic neoplasm+1

Not recruiting

Registered drug

Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Paracetamol

Contact Research Centre

Insomnia

Not recruiting

Registered drugNo placebo

Study on Amitriptyline and Cognitive Behavioral Therapy for Patients with Chronic Insomnia and Medical Conditions

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Amitriptyline Hydrochloride

Contact Research Centre

Anxiety disorder+1

Not recruiting

Investigational

Study on Cannabidiol for Reducing Anxiety and PTSD Symptoms in Dutch Uniformed Personnel

Investigational

The Netherlands

Participants:18–64 years
Substances:Cannabidiol

Contact Research Centre

Colon cancer+1

Not recruiting

Registered drugNo placebo

Study on the Impact of DPYD Gene Test on the Safety and Efficacy of Fluorouracil, Capecitabine, and Tegafur in Finnish Patients with Breast or Colon Cancer

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Thermal burn

Not recruiting

InvestigationalNo placebo

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Nofazinlimab and Lenvatinib for Patients with Advanced Liver Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Bone marrow disorder+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study of Metronomic Oral Vinorelbine with Durvalumab and Tremelimumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Find therapies in clinical trials near you – page 854

10 273 trials match your criteria

Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Bladder transitional cell carcinoma+2

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Metastatic neoplasm+1

Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

Insomnia

Study on Amitriptyline and Cognitive Behavioral Therapy for Patients with Chronic Insomnia and Medical Conditions

Anxiety disorder+1

Study on Cannabidiol for Reducing Anxiety and PTSD Symptoms in Dutch Uniformed Personnel

Colon cancer+1

Study on the Impact of DPYD Gene Test on the Safety and Efficacy of Fluorouracil, Capecitabine, and Tegafur in Finnish Patients with Breast or Colon Cancer

Thermal burn

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

Hepatocellular carcinoma

Study on the Effectiveness and Safety of Nofazinlimab and Lenvatinib for Patients with Advanced Liver Cancer

Bone marrow disorder+1

Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

Neoplasm malignant

Study of Metronomic Oral Vinorelbine with Durvalumab and Tremelimumab for Patients with Advanced Solid Tumors

Myelodysplastic syndrome

Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

Chronic lymphocytic leukaemia

Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.